In episode four of our "Clinical Viewpoints" video series, David Daniel, MD, our Head of CNS medicine, applies his years of in-depth knowledge and experience in the design and conduct of schizophrenia clinical trials to discuss the challenges and solutions in detecting treatment effects for positive and negative symptoms.
